Endoplasmic reticulum stress and Parkinson's disease: The role of HRD1 in averting apoptosis in neurodegenerative disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Omura, Tomohiro ^a   Kaneko, Masayuki ^b   Okuma, Yasunobu ^c   Matsubara, Kazuo ^a   Nomura, Yasuyuki ^d  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c CHIBA INSTITUTE OF SCIENCE   (Japan)

^d YOKOHAMA COLLEGE OF PHARMACY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEPILEPTIC DRUGS; ENDOPLASMIC RETICULUM STRESS; NEURODEGENERATIVE DISORDERS; NEURONAL DEATH; PARKINSON'S DISEASE; RECENT PROGRESS; UBIQUITIN LIGASES; UBIQUITINATION;

CELL MEMBRANES; NEURODEGENERATIVE DISEASES; NEURONS;

CELL DEATH;

ACTIVATING TRANSCRIPTION FACTOR 6; INITIATION FACTOR 2ALPHA; X BOX BINDING PROTEIN 1; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; MOLECULAR MECHANICS; NERVE DEGENERATION; PARKINSON DISEASE; REVIEW; UPREGULATION; ANIMAL; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; HUMANS; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84877302055     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/239854     Document Type: Review

References (75)

1. Schröder E. R., Kaufman R. J., ER stress and the unfolded protein response. Mutation Research 2005 569 29 63 (Pubitemid 39643256)
2. Ferri K. F., Kroemer G., Organelle-specific initiation of cell death pathways. Nature Cell Biology 2001 3 E255 E263
3. Marciniak S. J., Yun C. Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H. P., Ron D., CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes and Development 2004 18 24 3066 3077 2-s2.0-10644233167 10.1101/gad.1250704 (Pubitemid 39658175)
4. McCullough K. D., Martindale J. L., Klotz L. O., Aw T. Y., Holbrook N. J., Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state. Molecular and Cellular Biology 2001 21 4 1249 1259 2-s2.0-0035144493 10.1128/MCB.21.4.1249-1259.2001 (Pubitemid 32114973)
5. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., Yuan J., Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid- β Nature 2000 403 6765 98 103 2-s2.0-0034610743 10.1038/47513 (Pubitemid 30038529)
6. Hitomi J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., Manabe T., Yamagishi S., Bando Y., Imaizumi K., Tsujimoto Y., Tohyama M., Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A β -induced cell death. Journal of Cell Biology 2004 165 3 347 356 2-s2.0-2442432416 10.1083/jcb.200310015 (Pubitemid 38649910)
7. Harding H. P., Novoa I., Zhang Y., Regulated translation initiation controls stress-induced gene expression in mammalian cells. Molecular Cell 2000 6 5 1099 1108
8. Haze K., Yoshida H., Yanagi H., Yura T., Mori K., Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Molecular Biology of the Cell 1999 10 11 3787 3799 2-s2.0-0032693671 (Pubitemid 29534025)
9. Yoshida H., Okada T., Haze K., Yanagi H., Yura T., Negishi M., Mori K., ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Molecular and Cellular Biology 2000 20 18 6755 6767 2-s2.0-0033815971 10.1128/MCB.20.18.6755-6767.2000
10. Harding H. P., Zhang Y., Bertolotti A., Zeng H., Ron D., Perk is essential for translational regulation and cell survival during the unfolded protein response. Molecular Cell 2000 5 5 897 904 2-s2.0-0033634641 10.1016/S1097-2765(00)80330-5
11. Harding H. P., Zhang Y., Zeng H., An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Molecular Cell 2003 11 3 619 633 (Pubitemid 36385118)
12. Lee A. H., Iwakoshi N. N., Glimcher L. H., XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Molecular and Cellular Biology 2003 23 21 7448 7459 2-s2.0-0142059951 10.1128/MCB.23.21.7448-7459.2003 (Pubitemid 37271447)
13. Hershko A., Ciechanover A., The ubiquitin system. Annual Review of Biochemistry 1998 67 425 479 2-s2.0-0031657807 10.1146/annurev.biochem.67.1.425 (Pubitemid 28411135)
14. Zheng N., Wang P., Jeffrey P. D., Pavletich N. P., Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 2000 102 4 533 539 2-s2.0-0034682718
15. Allen J. R., Nguyen L. X., Sargent K. E. G., Lipson K. L., Hackett A., Urano F., High ER stress in β -cells stimulates intracellular degradation of misfolded insulin. Biochemical and Biophysical Research Communications 2004 324 1 166 170 2-s2.0-4744374044 10.1016/j.bbrc.2004.09.035 (Pubitemid 39311474)
16. Özcan U., Cao Q., Yilmaz E., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004 306 5695 457 461 (Pubitemid 39372439)
17. Özcan U., Yilmaz L E., Özcan, Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006 313 1137 1140 (Pubitemid 44300242)
18. Amano T., Yamasaki S., Yagishita N., Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes and Development 2003 17 19 2436 2449 (Pubitemid 37214791)
19. Gao B., Lee S. M., Chen A., Zhang J., Zhang D. D., Kannan K., Ortmann R. A., Fang D., Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis. EMBO Reports 2008 9 5 480 485 2-s2.0-43049096083 10.1038/embor.2008.37 (Pubitemid 351627287)
20. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., Takahashi R., An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 2001 105 7 891 902 2-s2.0-0035967883 10.1016/S0092-8674(01)00407-X (Pubitemid 32635090)
21. Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S., Selkoe D. J., Ubiquitination of a new form of α -synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001 293 5528 263 269 2-s2.0-0035854437 10.1126/science.1060627 (Pubitemid 32694735)
22. Holtz W. A., O'Malley K. L., Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. Journal of Biological Chemistry 2003 278 21 19367 19377 2-s2.0-0038143287 10.1074/jbc.M211821200 (Pubitemid 36799332)
23. Hoozemans J. J. M., van Haastert E. S., Eikelenboom P., Activation of the unfolded protein response in Parkinson's disease. Biochemistry and Biophysical Research Communications 2007 354 707 711 (Pubitemid 46186242)
24. Kaneko M., Koike H., Saito R., Kitamura Y., Okuma Y., Nomura Y., Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid- β generation. Journal of Neuroscience 2010 30 11 3924 3932 2-s2.0-77949764687 10.1523/JNEUROSCI.2422-09.2010
25. McLaughlin M., Vandenbroeck K., The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery? British Journal of Pharmacology 2011 162 2 328 345 2-s2.0-78650338184 10.1111/j.1476-5381.2010. 01064.x
26. Chadwick W., Mitchell N., Martin B., Maudsley S., Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease. Current Alzheimer Research 2012 9 1 110 119
27. Jeschke M. G., Boehning D., Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes. Journal of Cellular and Molecular Medicine 2012 16 3 437 444
28. Gilbert J. J., Kish S. J., Chang L. J., Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology 1988 24 5 688 691 (Pubitemid 18262675)
29. Damier P., Hirsch E. C., Agid Y., Graybiel A. M., The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999 122 8 1437 1448 2-s2.0-0032816549 10.1093/brain/122.8.1437 (Pubitemid 29374122)
30. Lesage S., Brice A., Parkinson's disease: from monogenic forms to genetic susceptibility factors. Human Molecular Genetics 2009 18 1 R48 R59 2-s2.0-63149090431 10.1093/hmg/ddp012
31. Wider C., Foroud T., Wszolek Z. K., Clinical implications of gene discovery in Parkinson's disease and parkinsonism. Movement Disorders 2010 25 1 S15 S20 2-s2.0-77953458926 10.1002/mds.22723
32. Satake W., Nakabayashi Y., Mizuta I., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature Genetics 2009 41 12 1303 1307
33. Simon-Sanchez J., Schulte C., Bras J. M., Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics 2009 41 12 1308 1312
34. Imai Y., Soda M., Takahashi R., Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. Journal of Biological Chemistry 2000 275 46 35661 35664 2-s2.0-0034680913 10.1074/jbc.C000447200
35. Ding X., Goldberg M. S., Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS ONE 2009 4 6 2-s2.0-67650164931 10.1371/journal. pone.0005949 e5949
36. Ko H. S., Bailey R., Smith W. W., CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2897 2902
37. Shimura H., Hattori N., Kubo S. I., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genetics 2000 25 3 302 305 2-s2.0-0033933048 10.1038/77060 (Pubitemid 30437317)
38. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998 392 6676 605 608 2-s2.0-0032499264 10.1038/33416 (Pubitemid 28207717)
39. Mizuno Y., Hattori N., Matsumine H., Neurochemical and neurogenetic correlates of Parkinson's disease. Journal of Neurochemistry 1998 71 3 893 902 2-s2.0-0031848638 (Pubitemid 28390243)
40. Murakami T., Shoji M., Imai Y., Pael-R is accumulated in Lewy bodies of Parkinson's disease. Annals of Neurology 2004 55 3 439 442 (Pubitemid 38269599)
41. Goldberg M. S., Fleming S. M., Palacino J. J., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. Journal of Biological Chemistry 2003 278 44 43628 43635 (Pubitemid 37345989)
42. Itier J. M., Ibanez P., Mena M. A., Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Human Molecular Genetics 2003 12 18 2277 2291 (Pubitemid 37160872)
43. Perez F. A., Palmiter R. D., Parkin-deficient mice are not a robust model of parkinsonism. Proceedings of the National Academy of Sciences of the United States of America 2005 102 6 2174 2179 2-s2.0-13844313915 10.1073/pnas. 0409598102 (Pubitemid 40262031)
44. Wang H. Q., Imai Y., Inoue H., Kataoka A., Iita S., Nukina N., Takahashi R., Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss. Journal of Neurochemistry 2008 107 1 171 185 2-s2.0-51849134081 10.1111/j.1471-4159.2008. 05607.x
45. Deng H., Dodson M. W., Huang H., Guo M., The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14503 14508 2-s2.0-55749090654 10.1073/pnas.0803998105
46. Poole A. C., Thomas R. E., Andrews L. A., McBride H. M., Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway regulates mitochondrial morphology. Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1638 1643 2-s2.0-39449088321 10.1073/pnas.0709336105 (Pubitemid 351346567)
47. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C. A., Sou Y. S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K., PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. Journal of Cell Biology 2010 189 2 211 221 2-s2.0-77951181836 10.1083/jcb.200910140
48. Okatsu K., Oka T., Iguchi M., PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nature Communications 2012 3 1016
49. Kaneko M., Ishiguro M., Niinuma Y., Uesugi M., Nomura Y., Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Letters 2002 532 1-2 147 152 2-s2.0-0037021416 10.1016/S0014-5793(02)03660- 8 (Pubitemid 35375880)
50. Denic V., Quan E. M., Weissman J. S., A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation. Cell 2006 126 2 349 359 2-s2.0-33746208871 10.1016/j.cell.2006.05.045 (Pubitemid 44092967)
51. Carvalho P., Stanley A. M., Rapoport T. A., Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase hrd1p. Cell 2010 143 4 579 591 2-s2.0-78149482323 10.1016/j.cell.2010.10.028
52. Deak P. M., Wolf D. H., Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation. Journal of Biological Chemistry 2001 276 14 10663 10669 2-s2.0-0035815754 10.1074/jbc.M008608200 (Pubitemid 38089236)
53. Kaneko M., Nomura Y., ER signaling in unfolded protein response. Life Sciences 2003 74 2-3 199 205 (Pubitemid 37357051)
54. Christianson J. C., Shaler T. A., Tyler R. E., Kopito R. R., OS-9 and GRP94 deliver mutant α 1-antitrypsin to the Hrd1?SEL1L ubiquitin ligase complex for ERAD. Nature Cell Biology 2008 10 3 272 282 2-s2.0-40249088336 10.1038/ncb1689 (Pubitemid 351331014)
55. Ye Y., Shibata Y., Kikkert M., Van Voorden S., Wiertz E., Rapoport T. A., Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proceedings of the National Academy of Sciences of the United States of America 2005 102 40 14132 14138 2-s2.0-26444621357 10.1073/pnas.0505006102 (Pubitemid 41429665)
56. Omura T., Kaneko M., Okuma Y., A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin. Journal of Neurochemistry 2006 99 6 1456 1469 (Pubitemid 44924225)
57. Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O., Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Research 2001 8 2 85 95 2-s2.0-0035958015 (Pubitemid 33617355)
58. Unterberger U., Voigtländer T., Budka H., Pathogenesis of prion diseases. Acta Neuropathologica 2005 109 1 32 48 2-s2.0-14244268370 10.1007/s00401-004-0953-9 (Pubitemid 40287788)
59. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B., Young A. B., Differential loss of striatal projection neurons in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 1988 85 15 5733 5737 2-s2.0-0001589776
60. van Gaalen J., Giunti P., van de Warrenburg B. P., Movement disorders in spinocerebellar ataxias. Movement Disorders 2011 26 5 792 800 2-s2.0-79955085928 10.1002/mds.23584
61. Omura T., Kaneko M., Onoguchi M., Koizumi S., Itami M., Ueyama M., Okuma Y., Nomura Y., Novel functions of ubiquitin ligase HRD1 with transmembrane and proline-rich domains. Journal of Pharmacological Sciences 2008 106 3 512 519 2-s2.0-41549116799 10.1254/jphs.08005FP (Pubitemid 351468605)
62. Fonseca S. G., Ishigaki S., Oslowski C. M., Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. Journal of Clinical Investigation 2010 120 3 744 755
63. Kudo T., Kanemoto S., Hara H., Morimoto N., Morihara T., Kimura R., Tabira T., Imaizumi K., Takeda M., A molecular chaperone inducer protects neurons from ER stress. Cell Death and Differentiation 2008 15 2 364 375 2-s2.0-38049170584 10.1038/sj.cdd.4402276
64. Engin F., Hotamisligil G. S., Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes, Obesity and Metabolism 2010 12 supplement 2 108 115 2-s2.0-77957316569 10.1111/j.1463-1326.2010.01282.x
65. Rajan R. S., Tsumoto K., Tokunaga M., Tokunaga H., Kita Y., Arakawa T., Chemical and pharmacological chaperones|application for recombinant protein production and protein folding diseases. Current Medicinal Chemistry 2011 18 1 1 15 2-s2.0-78751550063 10.2174/092986711793979698
66. Kubota K., Niinuma Y., Kaneko M., Okuma Y., Sugai M., Omura T., Uesugi M., Uehara T., Hosoi T., Nomura Y., Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. Journal of Neurochemistry 2006 97 5 1259 1268 2-s2.0-33646581674 10.1111/j.1471-4159.2006. 03782.x (Pubitemid 43725566)
67. Mimori S., Okuma Y., Kaneko M., Protective effects of 4-phenylbutyrate derivatives on the neuronal cell death and endoplasmic reticulum stress. Biological and Pharmaceutical Bulletin 2012 35 1 84 90
68. Ono K., Ikemoto M., Kawarabayashi T., Ikeda M., Nishinakagawa T., Hosokawa M., Shoji M., Takahashi M., Nakashima M., A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α -synuclein A30P + A53T transgenic mice. Parkinsonism and Related Disorders 2009 15 9 649 654 2-s2.0-70350150325 10.1016/j.parkreldis.2009.03.002
69. Ricobaraza A., Cuadrado-Tejedor M., Garcia-Osta A., Long-term phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing Abeta. Frontiers in Bioscience (Elite Edition) 2011 3 1375 1384
70. Omura T., Asari M., Yamamoto J., HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells. Journal of Molecular Neuroscience 2012 46 3 527 535
71. Murata M., Horiuchi E., Kanazawa I., Zonisamide has beneficial effects on Parkinson's disease patients. Neuroscience Research 2001 41 4 397 399 2-s2.0-0035656346 (Pubitemid 33733759)
72. Murata M., Hasegawa K., Kanazawa I., Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology 2007 68 1 45 50 (Pubitemid 46058551)
73. Langston J. W., The Parkinson's complex: Parkinsonism is just the tip of the Iceberg. Annals of Neurology 2006 59 4 591 596 2-s2.0-33645755812 10.1002/ana.20834
74. Federico A., Cardaioli E., Da Pozzo P., Mitochondria, oxidative stress and neurodegeneration. Journal of the Neurological Sciences 2012 322 1-2 254 262
75. Abbott R. D., Ross G. W., White L. R., Sanderson W. T., Burchfiel C. M., Kashon M., Sharp D. S., Masaki K. H., Curb J. D., Petrovitch H., Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. Journal of Neurology, Supplement 2003 250 3 30 39 2-s2.0-10744227681 (Pubitemid 37297084)